⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

IKS - Fundamental Analysis: Financial Health & Valuation

Back to List

Rating: 4.2

Last Updated Time : 25 May 26, 01:36 am

Fundamental Rating: 4.2

Stock Code IKS Market Cap 27,123 Cr. Current Price 1,580 ₹ High / Low 1,876 ₹
Stock P/E 47.9 Book Value 104 ₹ Dividend Yield 0.00 % ROCE 44.0 %
ROE 37.6 % Face Value 1.00 ₹ DMA 50 1,552 ₹ DMA 200 1,574 ₹
Chg in FII Hold 0.63 % Chg in DII Hold 0.34 % PAT Qtr 169 Cr. PAT Prev Qtr 146 Cr.
RSI 54.2 MACD 40.0 Volume 76,981 Avg Vol 1Wk 1,26,611
Low price 1,262 ₹ High price 1,876 ₹ PEG Ratio 1.80 Debt to equity 0.06
52w Index 51.8 % Qtr Profit Var 69.3 % EPS 33.0 ₹ Industry PE 26.2

📊 Core Financials: IKS demonstrates strong fundamentals with ROCE at 44.0% and ROE at 37.6%, reflecting excellent capital efficiency. Debt-to-equity ratio of 0.06 highlights a low-leverage structure. Quarterly PAT of ₹169 Cr. improved from ₹146 Cr., showing consistent growth. EPS of ₹33.0 supports earnings strength and profitability momentum.

💰 Valuation Indicators: Current P/E of 47.9 is significantly above the industry average of 26.2, suggesting overvaluation. P/B ratio of ~15.2 (1580/104) reflects premium pricing. PEG ratio of 1.80 indicates growth is fairly priced but not cheap. Dividend yield of 0% offers no income return. Intrinsic value appears lower than current price, requiring cautious entry.

🏢 Business Model & Competitive Advantage: IKS operates with a strong business model, leveraging innovation and efficiency. Its competitive advantage lies in high profitability, strong institutional support, and low debt. Consistent profit growth and scalability strengthen its long-term outlook.

📈 Entry Zone: RSI at 54.2 suggests neutral momentum, while MACD positive indicates bullish trend. Current price of ₹1,580 is near DMA levels (50 DMA: ₹1,552, 200 DMA: ₹1,574). Entry between ₹1,500–₹1,550 may be favorable for long-term investors.

Long-Term Holding Guidance: Strong fundamentals, low debt, and consistent profitability make IKS a solid candidate for long-term holding. However, high valuation warrants cautious entry. Investors should accumulate near support levels for compounding potential.


Positive

  • 🌟 High ROCE (44.0%) and ROE (37.6%)
  • 🌟 Low debt-to-equity ratio (0.06)
  • 🌟 Consistent quarterly PAT growth (₹146 Cr. → ₹169 Cr.)
  • 🌟 Strong institutional interest (FII +0.63%, DII +0.34%)

Limitation

  • ⚠️ High P/E (47.9) compared to industry average (26.2)
  • ⚠️ P/B ratio of 15.2 indicates premium valuation
  • ⚠️ No dividend yield

Company Negative News

  • 📉 Valuation concerns due to high P/E and P/B

Company Positive News

  • 📈 Strong quarterly profit growth (+69.3%)
  • 📈 Increase in both FII and DII holdings

Industry

  • 🌐 Industry P/E at 26.2 reflects moderate valuation
  • 🌐 Sector growth supported by demand and innovation
  • 🌐 IKS positioned well with strong profitability and efficiency

Conclusion

✅ IKS shows strong fundamentals, efficient capital returns, and low debt. Entry between ₹1,500–₹1,550 is favorable for long-term investors. While valuations are high, consistent profitability and institutional support make it a reliable candidate for compounding wealth.

Would you like me to also compare IKS with peers such as Persistent Systems or LTIMindtree to highlight sector positioning?

Technical Analysis
Fundamental Analysis

NIFTY 50 - Fundamental Stock Watchlist

NEXT 50 - Fundamental Stock Watchlist

MIDCAP - Fundamental Stock Watchlist

SMALLCAP - Fundamental Stock Watchlist